{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:25:20Z","timestamp":1789950320168,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T00:00:00Z","timestamp":1493856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"crossref","award":["6-2016-0079"],"award-info":[{"award-number":["6-2016-0079"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Korean government","award":["NRF-2014R1A1A1002198"],"award-info":[{"award-number":["NRF-2014R1A1A1002198"]}]},{"name":"Korean government","award":["NRF-2015R1A2A2A01002308"],"award-info":[{"award-number":["NRF-2015R1A2A2A01002308"]}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.omtn.2017.05.001","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T01:32:28Z","timestamp":1494293548000},"page":"396-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Periostin-Binding DNA Aptamer Treatment Ameliorates Peritoneal Dialysis-Induced Peritoneal Fibrosis"],"prefix":"10.1016","volume":"7","author":[{"given":"Bo Young","family":"Nam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Tak","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Eun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Pyo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Ha","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youndong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonghun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Eun","family":"Um","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyeok","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hyun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2017.05.001_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3747\/pdi.2010.00234","article-title":"Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: recent clinical practice in Japan","volume":"32","author":"Ayuzawa","year":"2012","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.omtn.2017.05.001_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1525-139X.2012.01124.x","article-title":"Advances in peritoneal dialysis: a review","volume":"25","author":"Bargman","year":"2012","journal-title":"Semin. Dial."},{"key":"10.1016\/j.omtn.2017.05.001_bib3","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1681\/ASN.2009070694","article-title":"The pathophysiology of the peritoneal membrane","volume":"21","author":"Devuyst","year":"2010","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"issue":"Suppl 4","key":"10.1016\/j.omtn.2017.05.001_bib4","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1177\/089686080002004S04","article-title":"Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment","volume":"20","author":"Kawaguchi","year":"2000","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.omtn.2017.05.001_bib5","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1177\/089686089501507S04","article-title":"First-line defense mechanisms in the peritoneal cavity during peritoneal dialysis","volume":"15","author":"Brulez","year":"1995","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.omtn.2017.05.001_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa020809","article-title":"Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells","volume":"348","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2017.05.001_bib7","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1046\/j.1523-1755.2003.00861.x","article-title":"Myofibroblastic conversion of mesothelial cells","volume":"63","author":"Yang","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtn.2017.05.001_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1681\/ASN.2004060436","article-title":"Transient overexpression of TGF-beta1 induces epithelial mesenchymal transition in the rodent peritoneum","volume":"16","author":"Margetts","year":"2005","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtn.2017.05.001_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/039139880502800208","article-title":"Cytokines and growth factors involved in peritoneal fibrosis of peritoneal dialysis patients","volume":"28","author":"Oh","year":"2005","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.omtn.2017.05.001_bib10","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1159\/000142529","article-title":"The role of the TGF\/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions","volume":"109","author":"Yao","year":"2008","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.omtn.2017.05.001_bib11","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1359\/jbmr.1999.14.7.1239","article-title":"Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta","volume":"14","author":"Horiuchi","year":"1999","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.omtn.2017.05.001_bib12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00198-011-1892-7","article-title":"The multiple facets of periostin in bone metabolism","volume":"23","author":"Merle","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.omtn.2017.05.001_bib13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jcb.21224","article-title":"Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues","volume":"101","author":"Norris","year":"2007","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.omtn.2017.05.001_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1600-0625.2012.01454.x","article-title":"Periostin, a matricellular protein, accelerates cutaneous wound repair by activating dermal fibroblasts","volume":"21","author":"Ontsuka","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.omtn.2017.05.001_bib15","doi-asserted-by":"crossref","first-page":"11131","DOI":"10.1128\/MCB.25.24.11131-11144.2005","article-title":"Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype","volume":"25","author":"Rios","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.omtn.2017.05.001_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3747\/pdi.2010.00259","article-title":"Periostin: a matricellular protein involved in peritoneal injury during peritoneal dialysis","volume":"33","author":"Braun","year":"2013","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.omtn.2017.05.001_bib17","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/s120100612","article-title":"Aptamers and their biological applications","volume":"12","author":"Song","year":"2012","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.omtn.2017.05.001_bib18","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2017.05.001_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1517\/14656566.9.3.499","article-title":"Pegaptanib sodium for the treatment of age-related macular degeneration","volume":"9","author":"Apte","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.omtn.2017.05.001_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2741\/1782","article-title":"HIV-1 inactivation by nucleic acid aptamers","volume":"11","author":"Held","year":"2006","journal-title":"Front. Biosci."},{"key":"10.1016\/j.omtn.2017.05.001_bib21","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/mt.2013.30","article-title":"Periostin-binding DNA aptamer inhibits breast cancer growth and metastasis","volume":"21","author":"Lee","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2017.05.001_bib22","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1681\/ASN.V13112787","article-title":"Acquired ultrafiltration dysfunction in peritoneal dialysis patients","volume":"13","author":"Margetts","year":"2002","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtn.2017.05.001_bib23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","article-title":"Morphologic changes in the peritoneal membrane of patients with renal disease","volume":"13","author":"Williams","year":"2002","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"issue":"Suppl 2","key":"10.1016\/j.omtn.2017.05.001_bib24","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1177\/089686080702702s12","article-title":"Mediators of inflammation and fibrosis","volume":"27","author":"Lai","year":"2007","journal-title":"Perit. Dial. Int."},{"issue":"Suppl 2","key":"10.1016\/j.omtn.2017.05.001_bib25","first-page":"S348","article-title":"Effect of peritoneal dialysis on peritoneal cell biology: peritoneal fibroblasts","volume":"19","author":"J\u00f6rres","year":"1999","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.omtn.2017.05.001_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3747\/pdi.2014.00188","article-title":"Transition of mesothelial cell to fibroblast in peritoneal dialysis: EMT, stem cell or bystander?","volume":"35","author":"Liu","year":"2015","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.omtn.2017.05.001_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrneph.2009.74","article-title":"Fibroblast activation and myofibroblast generation in obstructive nephropathy","volume":"5","author":"Grande","year":"2009","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.omtn.2017.05.001_bib28","doi-asserted-by":"crossref","first-page":"473134","DOI":"10.1155\/2014\/473134","article-title":"Mesenchymal conversion of mesothelial cells is a key event in the pathophysiology of the peritoneum during peritoneal dialysis","volume":"2014","author":"L\u00f3pez-Cabrera","year":"2014","journal-title":"Adv. Med."},{"key":"10.1016\/j.omtn.2017.05.001_bib29","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3346\/jkms.2007.22.6.943","article-title":"Mechanisms of epithelial-mesenchymal transition of peritoneal mesothelial cells during peritoneal dialysis","volume":"22","author":"Lee","year":"2007","journal-title":"J.\u00a0Korean Med. Sci."},{"issue":"Suppl 2","key":"10.1016\/j.omtn.2017.05.001_bib30","doi-asserted-by":"crossref","first-page":"ii2","DOI":"10.1093\/ndt\/gfl183","article-title":"Epithelial-to-mesenchymal transition of the mesothelial cell--its role in the response of the peritoneum to dialysis","volume":"21","author":"Selgas","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.omtn.2017.05.001_bib31","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1097\/01.ASN.0000033611.79556.AE","article-title":"TGF-beta signaling in renal disease","volume":"13","author":"B\u00f6ttinger","year":"2002","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtn.2017.05.001_bib32","first-page":"64","article-title":"Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence","volume":"13","author":"Lin","year":"1997","journal-title":"Adv. Perit. Dial."},{"key":"10.1016\/j.omtn.2017.05.001_bib33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000232937","article-title":"Association between markers of inflammation, fibrosis and hypervolemia in peritoneal dialysis patients","volume":"28","author":"Gangji","year":"2009","journal-title":"Blood Purif."},{"key":"10.1016\/j.omtn.2017.05.001_bib34","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1681\/ASN.V12102029","article-title":"Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function","volume":"12","author":"Margetts","year":"2001","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtn.2017.05.001_bib35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGF\u03b2 signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2017.05.001_bib36","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1046\/j.1523-1755.2000.00414.x","article-title":"Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction","volume":"58","author":"Miyajima","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtn.2017.05.001_bib37","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2337\/diab.45.4.522","article-title":"Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice","volume":"45","author":"Sharma","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.omtn.2017.05.001_bib38","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1073\/pnas.120055097","article-title":"Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db\/db diabetic mice","volume":"97","author":"Ziyadeh","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2017.05.001_bib39","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/art.22289","article-title":"Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I\/II trial of CAT-192","volume":"56","author":"Denton","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.omtn.2017.05.001_bib40","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2215\/CJN.01050207","article-title":"Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis","volume":"2","author":"Cho","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.omtn.2017.05.001_bib41","first-page":"41","article-title":"Inhibition of transforming growth factor beta (TGFbeta1) expression and extracellular matrix secretion in human peritoneal mesothelial cells by pcDU6 vector-mediated TGFbeta1 shRNA and by pcDNA3.1(-)-mediated antisense TGFbeta1 RNA","volume":"21","author":"Liu","year":"2005","journal-title":"Adv. Perit. Dial."},{"key":"10.1016\/j.omtn.2017.05.001_bib42","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1158\/1078-0432.CCR-07-1157","article-title":"Transforming growth factor-beta and the immune response: implications for anticancer therapy","volume":"13","author":"Wrzesinski","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2017.05.001_bib43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00428-011-1151-5","article-title":"Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update","volume":"459","author":"Morra","year":"2011","journal-title":"Virchows Arch."},{"key":"10.1016\/j.omtn.2017.05.001_bib44","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1681\/ASN.2013060664","article-title":"Inhibition of periostin expression protects against the development of renal inflammation and fibrosis","volume":"25","author":"Mael-Ainin","year":"2014","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtn.2017.05.001_bib45","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/ki.1990.150","article-title":"Isolation, culture and characterization of human peritoneal mesothelial cells","volume":"37","author":"Stylianou","year":"1990","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtn.2017.05.001_bib46","doi-asserted-by":"crossref","first-page":"19971","DOI":"10.1073\/pnas.1213933109","article-title":"Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets","volume":"109","author":"Davies","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2017.05.001_bib47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1523-1755.2001.060002543.x","article-title":"p38 MAPK and MAPK kinase 3\/6 mRNA and activities are increased in early diabetic glomeruli","volume":"60","author":"Kang","year":"2001","journal-title":"Kidney Int."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253117301713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253117301713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T10:17:20Z","timestamp":1659003440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253117301713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":47,"alternative-id":["S2162253117301713"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2017.05.001","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Periostin-Binding DNA Aptamer Treatment Ameliorates Peritoneal Dialysis-Induced Peritoneal Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2017.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s).","name":"copyright","label":"Copyright"}]}}